[Primary liver and bile duct tumors: approach to conservative therapy].

D Henne-Bruns, H G Marks
{"title":"[Primary liver and bile duct tumors: approach to conservative therapy].","authors":"D Henne-Bruns,&nbsp;H G Marks","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>In case of non-resectable primary liver cancer the following treatment modalities can be applied: ligation, embolization or balloon occlusion of the hepatic artery, locoregional chemotherapy, percutaneous ethanol or acetic acid injection, microwave application, and cryotherapy, as well as combined therapeutic modalities. The 3-year survival rates for patients with small hepatocellular carcinomas (HCCs) are comparable for the different procedures (resection, ethanol- or acetic acid injection, cryotherapy, microwave application) and range between 60-80%. In patients with larger HCCs the prognosis seems to be improved by a combination treatment of chemoembolization and ethanol injection compared to chemoembolization alone.</p>","PeriodicalId":77239,"journal":{"name":"Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress","volume":"115 ","pages":"343-7"},"PeriodicalIF":0.0000,"publicationDate":"1998-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In case of non-resectable primary liver cancer the following treatment modalities can be applied: ligation, embolization or balloon occlusion of the hepatic artery, locoregional chemotherapy, percutaneous ethanol or acetic acid injection, microwave application, and cryotherapy, as well as combined therapeutic modalities. The 3-year survival rates for patients with small hepatocellular carcinomas (HCCs) are comparable for the different procedures (resection, ethanol- or acetic acid injection, cryotherapy, microwave application) and range between 60-80%. In patients with larger HCCs the prognosis seems to be improved by a combination treatment of chemoembolization and ethanol injection compared to chemoembolization alone.

原发性肝脏和胆管肿瘤:保守治疗的方法。
对于不可切除的原发性肝癌,可采用结扎、肝动脉栓塞或球囊闭塞、局部化疗、经皮乙醇或醋酸注射、微波应用、冷冻治疗等治疗方式,也可采用综合治疗方式。小肝细胞癌(hcc)患者的3年生存率在不同的治疗方法(切除、乙醇或乙酸注射、冷冻治疗、微波应用)下是相当的,范围在60-80%之间。在hcc较大的患者中,与单独化疗栓塞相比,化疗栓塞和乙醇注射联合治疗似乎可以改善预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信